Skip to main content

Verdict on Trump drug plan: A tough sale ahead

This article discusses the uphill battle that the current Trump administration is facing regarding its plans to make lower Medicare drug costs a reality. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is among the sources quoted providing commentary in the piece.